The following sections summarize genetic associations of S1R mutations/polymorphisms with neurodegenerative diseases, examples of neuroprotection in respective disorders by S1R agonists, and possible mechanisms of action. The gene discussed is TMBIM4; the disease is neurodegenerative disease.